AzTrials
AzTrials

Peripheral Nerve DiseaseNCT06569563

Innervation Characteristics and Determination of Nerve Entry Points of the Musculus Semispinalis Capitis

An observational study of Peripheral Nerve Disease and Muscular Injury, run by Medipol University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to determine the innervation characteristics and nerve entry points of the musculus semispinalis capitis. This muscle, which is involved in the extension of the head and neck, is a large and long cervico-thoracic muscle innervated by the dorsal rami of the cervical spinal nerves. Read more about this study

Who is it for?
Ages 45 to 75 years
Conditions the study is for
Peripheral Nerve Disease, Muscular Injury
How many people
20 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Aug 2018to 14 Jun 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study was conducted using 10 adult male cadavers, aged between 45 and 75 years, that had been fixed in 10% formalin solution. These cadavers were sourced from the laboratory of the Department of Anatomy at Ege University Faculty of Medicine.

Who may be able to join

  • Cadavers were preserved using a 10% formalin solution.

Who cannot join

  • neck and back region curvature,
  • neck flexion and extension,
  • related region muscle or nerve pathology,
  • fracture,
  • cadavers that have undergone previous surgery

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Medipol University

    Istanbul, Kavacık, 34815

Other trials in Turkey (Türkiye)

About this study

The aim of this study is to determine the innervation characteristics and nerve entry points of the musculus semispinalis capitis. This muscle, which is involved in the extension of the head and neck, is a large and long cervico-thoracic muscle innervated by the dorsal rami of the cervical spinal nerves. The study seeks to enhance the effectiveness of procedures like electromyography (EMG) electrode placement and botulinum toxin injections used for diagnosing and treating conditions related to head and neck pain.

Accurately identifying these nerve entry points is crucial for ensuring the safety and efficacy of treatments, particularly for conditions like cervical dystonia and headaches. While existing studies have focused on the innervation and nerve mapping of various muscles, there has been no specific research on the nerve entry points of the musculus semispinalis capitis. This study aims to provide detailed knowledge of these aspects, offering valuable guidance for interventions in this area.

Read the detailed description

The musculus semispinalis capitis, one of the cervical paraspinal muscles, originates from the transverse processes of the last cervical and the first six to seven thoracic vertebrae. It extends upward along both sides of the posterior midline and inserts between the superior and inferior nuchal lines on the occipital bone. This muscle is innervated by the dorsal rami of the cervical spinal nerves. As a large and long cervico-thoracic muscle, its primary function is the extension of the head and neck.

The aim of this study is to determine the innervation characteristics and nerve entry points of the musculus semispinalis capitis to enhance the effectiveness of procedures such as the placement of electromyography (EMG) electrodes for diagnostic and therapeutic purposes, as well as botulinum toxin injections used for treating conditions associated with head and neck pain.

The innervation characteristics and nerve entry points of the musculus semispinalis capitis need to be precisely identified, particularly in relation to treatments such as botulinum toxin injections for the management of spasms and pain in conditions like cervical dystonia, and for the treatment of headaches. Accurate identification of these points is crucial for ensuring safe and effective injections in this region and for understanding the anatomical variations in the area.

While there are studies in the literature focusing on the innervation characteristics and nerve entry points of various muscles, as well as nerve mapping, there has been no specific research on nerve entry point mapping for the musculus semispinalis capitis. Conducting this study will establish a detailed understanding of the innervation characteristics and nerve entry points of this muscle, providing valuable guidance for interventions in this area.

Previous studies on deep neck muscles have shown that procedures such as injections and EMG measurements have generally been performed using approximate localization methods. This study aims to use the results obtained to make these procedures more effective and less invasive.

Keywords
m. semispinalis capitis, paraspinal muscle, muscle innervation mapping, cervical spine surgery, musculoskeletal anatomy, nerve entry point, intramuscular injection, cervical dystonia, botulinum toxin injections, innervation
Medical subject headings
Peripheral Nervous System Diseases, Torticollis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The number of nerves innervating the semispinalis capitis muscle

    The semispinalis capitis muscle is innervated by many nerves, primarily the dorsal branches of the cervical spinal nerves. The number of branches of the dorsal branches of the cervical nerves that enter the muscle was determined and counted one by one.

    Measured: 10 months

  2. The location of nerves innervating the semispinalis capitis muscle

    In order to determine which cervical nerve branch of the semispinalis capitis muscle was concentrated in which areas of the muscle, the perpendicular distances of the points where the nerves entered the muscle to the determined landmarks were measured and recorded in mm.

    Measured: 10 months

  3. The thickness of nerves innervating the semispinalis capitis muscle

    The thickness of the nerves innervating the semispinalis capitis muscle was measured and recorded.

    Measured: 10 months

  4. Mapping of nerves innervating the semispinalis capitis muscle

    After detailed information about the nerves innervating the semispinalis capitis muscle and the areas where they are concentrated were determined, the innervation map of the muscle was created. In this way, a muscle-nerve map was created as a guide for clinical applications.

    Measured: 10 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2024
  2. Study start1 Aug 2018
  3. Primary completion28 Dec 2018
  4. Study completion14 Jun 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06569563
Sponsor's protocol ID
İMU-SEDAGOZENER-002
Status last verified
Aug 2024
First submitted
15 Aug 2024
Last updated
26 Aug 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Robbins MS, Kuruvilla D, Blumenfeld A, Charleston L 4th, Sorrell M, Robertson CE, Grosberg BM, Bender SD, Napchan U, Ashkenazi A; Peripheral Nerve Blocks and Other Interventional Procedures Special Interest Section of the American Headache Society. Trigger point injections for headache disorders: expert consensus methodology and narrative review. Headache. 2014 Oct;54(9):1441-59. doi: 10.1111/head.12442. Epub 2014 Aug 28.

    PubMed 25168295
  • Rezasoltani A, Ahmadipoor A, Khademi-Kalantari K, Javanshir K. The sign of unilateral neck semispinalis capitis muscle atrophy in patients with chronic non-specific neck pain. J Back Musculoskelet Rehabil. 2012;25(1):67-72. doi: 10.3233/BMR-2012-0303.

    PubMed 22398268
  • Kaya B, Apaydin N, Loukas M, Tubbs RS. The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter. J Plast Reconstr Aesthet Surg. 2014 Dec;67(12):1663-8. doi: 10.1016/j.bjps.2014.07.043. Epub 2014 Aug 7.

    PubMed 25175271
  • Takebe K, Vitti M, Basmajian JV. The functions of semispinalis capitis and splenius capitis muscles: an electromyographic study. Anat Rec. 1974 Aug;179(4):477-80. doi: 10.1002/ar.1091790407. No abstract available.

    PubMed 4842939
  • Elliott JM, O'Leary SP, Cagnie B, Durbridge G, Danneels L, Jull G. Craniocervical orientation affects muscle activation when exercising the cervical extensors in healthy subjects. Arch Phys Med Rehabil. 2010 Sep;91(9):1418-22. doi: 10.1016/j.apmr.2010.05.014.

    PubMed 20801261

Questions about this trial

What is this clinical trial studying?

An observational study of Peripheral Nerve Disease and Muscular Injury, run by Medipol University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The number of nerves innervating the semispinalis capitis muscle (time frame: 10 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06569563, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in